Am J Transplant, Volume 5, Suppl 3 Archives - Page 117 of 170 - ATC Abstracts

2015 American Transplant Congress
Long-Term Follow-Up After Conversion from Twice-Daily Tacrolimus Formulation to Once-Daily Tacrolimus Formulation in Pediatric Kidney Transplantation
C. Choi, A. Han, S. Min, S.-K. Min, T. Lee, I.-M. Jung, S. Kim, J. Ha.
Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
PurposeTacrolimus is one of the most frequently used immunosuppressants in pediatric kidney transplantation (KT) as in adult. In Pediatric kidney recipients, it is more important…
2015 American Transplant Congress
Discrepancies Between the U.S. Transplant Registry and Cancer Registries Regarding Cancer Diagnoses in Transplant Recipients
E. Engels,¹ D. Segev,² J. Snyder,³ B. Kasiske,³ E. Yanik.¹
¹National Cancer Institute, Bethesda; ²Johns Hopkins Hospital, Baltimore; ³SRTR, Minneapolis.
Background: Transplant recipients have elevated cancer risk. US transplant centers report incident cancer diagnoses to the transplant network at yearly intervals, and these data are…
2015 American Transplant Congress
Industry Payments to Transplant Surgeons
R. Ahmed, E. Chow, A. Massie, E. King, B. Orandi, S. Bae, L. Nicholas, B. Lonze, D. Segev.
Johns Hopkins, Baltimore.
The Open Payments Program (OPP) was implemented to publicly disclose industry payments to physicians, enabling patients to be aware of potential conflicts of interest. Outcomes…
2015 American Transplant Congress
Human CMV-Specific CD8 T Cells Exhibit Distinct Phenotypes and Distribution Patterns in Tissues and Circulation
C. Gordon,^1,2,5 J. Thome,^1,3 G. Tomer,¹ D. Farber.^1,3,4
¹Columbia Center for Translational Immunology, Columbia University Medical Center, New York; ²Medicine, Columbia University Medical Center, New York; ³Microbiology and Immunology, Columbia University Medical Center, New York; ⁴Surgery, Columbia University Medical Center, New York; ⁵University of Melborne, Melbourne, Australia.
IntroductionCMV persists and is controlled by T cells in multiple tissues; however, study of CMV responses has largely been limited to blood containing only 2-3%…
2015 American Transplant Congress
Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence
C. Chinchilla-Reyes,^1,2 D. Tanglao,¹ T. Mone,³ M. Koss,¹ M. Nowicki.^1,2
¹Viracor-IBT Laboratories, Los Angeles; ²Mendez National Institute of Transplantation Foundation, Los Angeles; ³OneLegacy, Los Angeles.
West Nile Virus (WNV) symptoms develop 2-15 days after exposure with a short period of viremia (6-7 days). It is possible to detect WNV in…
2015 American Transplant Congress
Long-Term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients
S. Shin, Y. Kim, B. Choi, J. Choi, J. Jung, H. Cho, D. Han.
Asan Medical Center, Seoul, Korea.
Background Limited data are available on long-term metabolic outcomes of functioning pancreas transplants in patients with type 2 diabetes mellitus (T2DM). The aim of this…
2015 American Transplant Congress
Pediatrics & Donor Derived Disease Transmission: The US OPTN Experience
M. Green,¹ S. Taranto,² S. Covington,² M. Michaels,¹ C. Wolfe,³ D. Kaul.⁴
¹Pediatrics & Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; ²OPTN/UNOS, Richmond, VA; ³Medicine, Duke University School of Medicine, Durham, NC; ⁴Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Potential donor derived disease transmission events (PDDTE) are tracked by the OPTN DTAC. Specific evaluation of potential transmissions from pediatric (ped) donors or the impact…
2015 American Transplant Congress
ABO-Incompatible Live Donor Kidney Transplants Inferior to ABO-Compatible Transplants, but Match Deceased Donor Results: Is Kidney Paired Donation the Answer?
J. Verbesey, M. Cooper, A. Gilbert, M. Grafals, P. Weems, J. Moore, S. Ghasemian, C. Nilubol, B. Javaid.
Georgetown University School of Medicine, MedStar Georgetown Transplant Institute, Kidney and Pancreas Transplant Program, Washington, DC.
Objective: Compare kidney allograft survival in ABO-incompatible (ABO-I) and ABO-compatible (ABO-C) live donor kidney transplant recipients.Methods: We analyzed UNOS database for patients who underwent a…
2015 American Transplant Congress
Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction
H. Wadei, A. Peguero, A. Alsaad, M. Mai, K. Oshel, T. Gonwa, C. Taner, A. Keaveny.
Transplant, Mayo Clinic, Jacksonville, FL.
Renal dysfunction is common in LT candidates; however, predicting post-LT renal recovery is sometimes difficult. Kidney biopsy is helpful in identifying reversible renal injury but…
2015 American Transplant Congress
Examining Long-Term Survivors in Combined Heart-Lung Transplantation
S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
¹Department of Surgery, Temple University Hospital, Philadelphia, PA; ²Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA; ³Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA.
The goal of this study was to determine variables associated with mortality in combined heart-lung transplantation (HLT).The United Network for Organ Sharing (UNOS) database was…